Neoplasia/BPH

	Deciphering Resistance: Beyond the Androgen Paradigm; Report From the 2025 Coffey-Holden Prostate Cancer Academy Meeting. Prostate Stoyanova T, Priceman SJ, Ross AE, Tran PT, McKay RR, Pienta KJ, Soule HR, Miyahira AK. PMID: 41355303 [PubMed - as supplied by publisher]
	Radiomics Reproducibility in Prostate Cancer Diagnosis Based on PROSTATEx. Int Neurourol J Jung S, Kim JS. PMID: 41355262 [PubMed]
	Application of three-dimensional visualization reconstruction and digital virtual diagnosis and treatment technology in robot-assisted laparoscopic partial nephrectomy for complex renal tumors: a single-center retrospective study. BMC Surg Li C, Li R, Jing J, Qi W, Yang X, Zhang Y. PMID: 41354777 [PubMed - as supplied by publisher]
	A rapid urinary test for combining PSA and zinc to enhance prostate cancer diagnosis: results from a prospective study. Prostate Cancer Prostatic Dis Amparore D, De Cillis S, Zamengo D, Ortenzi M, Alladio E, Di Nardo F, Serra T, Occhipinti S, Fiori C, Porpiglia F. PMID: 41354696 [PubMed - as supplied by publisher]
	Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations. Eur Urol Focus Cheng HH, Callis S, Yu EY, Delacroix SE, Sokolova AO, Tangen CM, Lerner SP, Dorff TB, Lin DW. PMID: 41354605 [PubMed - as supplied by publisher]
	Neoadjuvant Systemic Therapy in High-risk Localised Prostate Cancer: Current Evidence and Future Directions. Eur Urol Focus Al-Khanaty A, Hennes D, Perera ML, Lawrentschuk N, Murphy DG, Eapen RS. PMID: 41354604 [PubMed - as supplied by publisher]
	Can novel biomarkers augment traditional surveillance paradigms in early-stage testicular germ cell tumors? A case study in pre-clinical relapse detection using a combination micro-RNA-371a-3p and 372-3p assay. Urology Huynh J, Levin A, D'Andrea V, Williams B, Knezevic A, Sheinfeld J, Ye F, Valentino A, Feldman DR, Funt SA, Matulewicz RS. PMID: 41354280 [PubMed - as supplied by publisher]
	Androgen deprivation therapy with apalutamide in the treatment of metastatic castration-sensitive prostate cancer: the systematic review of its effectiveness and applicability for Asian men in the targeted investigational treatment analysis of novel anti-androgen (TITAN) trial. Int Urol Nephrol Yang F, Feng L, Liu W, Liang S. PMID: 41353294 [PubMed - as supplied by publisher]
	A novel angiogenesis-related gene signature predicting prognosis in clear cell renal cell carcinoma. Sci Rep Xu YY, Cheng GB, Li XY, Zeng XX, Wu SY. PMID: 41353246 [PubMed - as supplied by publisher]
	Proteome-wide association study of prostate cancer risk across populations. Nat Commun Zhong H, Zhu J, Liu S, Wu C, Wang L, Whelton SP, Marshall CH, Blaha MJ, Durda P, Guo X, Johnson CW, Lin HJ, Taylor KD, Tracy RP, Yarden RI, Manichaikul AW, Rich SS, Rotter JI, Deo R, Dubin RF, Ganz P, Wu L. PMID: 41353205 [PubMed - as supplied by publisher]
	PARP Inhibitors in Prostate Cancer: Broad Use or Patient Selection? Eur Urol Focus González-Ginel I, Rodriguez-Antolin A, Olmos D, Castro E. PMID: 41353049 [PubMed - as supplied by publisher]
	Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study. Eur Urol Oncol Bianchi L, Droghetti M, Catanzaro C, Valerio M, Novello Q, Mari A, Campi R, Nicoletti R, Heidegger I, Giannini G, Zattoni F, Reitano G, Bauckneht M, Lanfranchi F, Rajwa P, Marra G, Soeterik T, den Bergh RV, Fendler WP, Darr C, Rivas JG, Kesch C, Mignogna C, Gandaglia G, Ceci F, Farolfi A, Gontero P, Fanti S, Masieri L, Serni S, Minervini A, Briganti A, Montorsi F, Schiavina R. PMID: 41353037 [PubMed - as supplied by publisher]
	Targeting MAO offers a novel immunotherapeutic strategy for prostate cancer by modulating the "tumor-stroma-immune" interaction network. Biochim Biophys Acta Rev Cancer Hu Y, Zhao Z, Ma Y, He X, Shi C. PMID: 41352489 [PubMed - as supplied by publisher]
	The role of manufacturer and user facility database in evaluating BPH and prostate cancer procedures. World J Urol Chughtai B, Venkatraman G, Gressler L, Elterman D, Bhojani N. PMID: 41351682 [PubMed - indexed for MEDLINE]
	Histone Modification Networks Reshape the Metabolism and Treatment Landscape of Urological Cancers. Front Biosci (Landmark Ed) Liu F, He L, Yu M, Chen J, Huang Y, Ma W, Wan Y, Zhou B. PMID: 41351419 [PubMed - indexed for MEDLINE]
	Developing a prediction model in a large case-control study for the early detection of bladder cancer. J Transl Med Tanaka S, Wilkens LR, Marchand LL, Yang G, Yuan JM, Koh WP, Shrubsole MJ, Luu M, Pagano I, Figueiredo JC, Furuya H, Rosser CJ. PMID: 41351005 [PubMed - as supplied by publisher]
	Preoperative predictors about lymph node metastasis and biochemical recurrence in high-risk prostate cancer patients: a clinic pathological retrospective study. BMC Urol Wang C, Wang G, Xiao L, Du H, Xu Y, Li S, Yang X. PMID: 41350993 [PubMed - as supplied by publisher]
	Staging Prostate Cancer with AI: A Comparative Study of Large Language Models and Expert Interpretation on PSMA PET-CT Reports. Mol Imaging Biol Ismayilov R, Aktas A, Gencoglu EA, Oguz A, Altundag O, Akcali Z. PMID: 41350971 [PubMed - as supplied by publisher]
	Infection risks and biopsy-associated complications in prostate cancer diagnosis: a review of recent literatures. Prostate Cancer Prostatic Dis Nikolaevich PV, Samuel AO, Fayazovich UM, Olaiya VO, Adesegun FA. PMID: 41350942 [PubMed - as supplied by publisher]
	Comparison of Retzius-sparing versus anterior robotic-assisted radical prostatectomy in patients with prior transurethral resection of the prostate (TURP). World J Urol Schütz V, Hatiboglu G, Würkner D, Tekesin M, Feisst M, Duensing S, Huber J, Hohenfellner M, Kaufmann B. PMID: 41350773 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 183704

Page 1 of 9186



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy